Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 37 | 2023 | 316 | 10.680 |
Why?
|
| Puerto Rico | 94 | 2023 | 1352 | 6.050 |
Why?
|
| Anus Neoplasms | 11 | 2023 | 47 | 5.430 |
Why?
|
| Uterine Cervical Neoplasms | 14 | 2021 | 248 | 4.670 |
Why?
|
| Alphapapillomavirus | 11 | 2021 | 37 | 3.280 |
Why?
|
| Early Detection of Cancer | 11 | 2021 | 292 | 3.120 |
Why?
|
| Papillomaviridae | 12 | 2023 | 125 | 2.970 |
Why?
|
| Papillomavirus Vaccines | 12 | 2021 | 136 | 2.540 |
Why?
|
| HIV Infections | 16 | 2023 | 2207 | 2.500 |
Why?
|
| Middle Aged | 71 | 2022 | 9642 | 2.320 |
Why?
|
| Young Adult | 50 | 2022 | 4012 | 2.210 |
Why?
|
| Periodontitis | 3 | 2022 | 52 | 2.090 |
Why?
|
| Adult | 70 | 2022 | 11034 | 2.060 |
Why?
|
| Female | 84 | 2023 | 19873 | 1.990 |
Why?
|
| Cross-Sectional Studies | 31 | 2022 | 2561 | 1.890 |
Why?
|
| Humans | 104 | 2023 | 34853 | 1.780 |
Why?
|
| Vaginal Smears | 4 | 2015 | 52 | 1.780 |
Why?
|
| Cervix Uteri | 4 | 2017 | 43 | 1.590 |
Why?
|
| Incidence | 19 | 2021 | 882 | 1.580 |
Why?
|
| Adolescent | 31 | 2021 | 5035 | 1.520 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2021 | 790 | 1.450 |
Why?
|
| Risk Factors | 29 | 2023 | 3414 | 1.440 |
Why?
|
| Mouth Neoplasms | 3 | 2018 | 70 | 1.400 |
Why?
|
| Neoplasms | 12 | 2020 | 1033 | 1.400 |
Why?
|
| Vulvar Neoplasms | 2 | 2018 | 12 | 1.340 |
Why?
|
| Prevalence | 20 | 2020 | 1425 | 1.340 |
Why?
|
| Colorectal Neoplasms | 5 | 2016 | 413 | 1.330 |
Why?
|
| Male | 62 | 2023 | 18870 | 1.290 |
Why?
|
| Aged | 36 | 2020 | 6448 | 1.290 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 252 | 1.110 |
Why?
|
| Mass Screening | 3 | 2021 | 427 | 1.000 |
Why?
|
| Registries | 8 | 2016 | 330 | 1.000 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 62 | 0.950 |
Why?
|
| DNA, Viral | 5 | 2017 | 295 | 0.940 |
Why?
|
| Genotype | 6 | 2023 | 641 | 0.930 |
Why?
|
| Sexual Behavior | 7 | 2015 | 587 | 0.920 |
Why?
|
| Obesity | 9 | 2020 | 965 | 0.910 |
Why?
|
| United States | 16 | 2021 | 3894 | 0.880 |
Why?
|
| Periodontal Diseases | 1 | 2022 | 49 | 0.860 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 176 | 0.840 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2013 | 8 | 0.840 |
Why?
|
| Earthquakes | 1 | 2021 | 6 | 0.840 |
Why?
|
| Penile Neoplasms | 2 | 2018 | 14 | 0.790 |
Why?
|
| Body Mass Index | 5 | 2020 | 775 | 0.790 |
Why?
|
| Age Factors | 8 | 2018 | 1007 | 0.760 |
Why?
|
| Anal Canal | 3 | 2021 | 28 | 0.760 |
Why?
|
| Endoscopy | 1 | 2020 | 15 | 0.740 |
Why?
|
| Biopsy | 2 | 2020 | 151 | 0.730 |
Why?
|
| Vaccination | 5 | 2021 | 259 | 0.730 |
Why?
|
| Bibliometrics | 2 | 2010 | 16 | 0.730 |
Why?
|
| Cytological Techniques | 1 | 2020 | 14 | 0.730 |
Why?
|
| Chlamydia trachomatis | 1 | 2020 | 66 | 0.720 |
Why?
|
| Video Recording | 1 | 2019 | 32 | 0.700 |
Why?
|
| Anus Diseases | 2 | 2016 | 17 | 0.690 |
Why?
|
| Patient Compliance | 1 | 2020 | 202 | 0.650 |
Why?
|
| Odds Ratio | 6 | 2018 | 517 | 0.630 |
Why?
|
| Chlamydia Infections | 1 | 2020 | 196 | 0.630 |
Why?
|
| Biomedical Research | 4 | 2012 | 371 | 0.620 |
Why?
|
| Insurance, Health | 2 | 2016 | 120 | 0.600 |
Why?
|
| Health Promotion | 3 | 2019 | 588 | 0.590 |
Why?
|
| Health Planning | 1 | 2016 | 16 | 0.580 |
Why?
|
| Government Programs | 1 | 2016 | 28 | 0.580 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 28 | 0.570 |
Why?
|
| Models, Theoretical | 1 | 2017 | 210 | 0.560 |
Why?
|
| Risk-Taking | 4 | 2015 | 435 | 0.560 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2017 | 214 | 0.560 |
Why?
|
| Logistic Models | 9 | 2018 | 894 | 0.560 |
Why?
|
| Seroepidemiologic Studies | 5 | 2020 | 67 | 0.550 |
Why?
|
| Specimen Handling | 2 | 2013 | 49 | 0.540 |
Why?
|
| Stomatitis | 1 | 2014 | 2 | 0.520 |
Why?
|
| Cardiovascular Diseases | 4 | 2015 | 628 | 0.520 |
Why?
|
| Comorbidity | 6 | 2018 | 606 | 0.510 |
Why?
|
| Mouth | 1 | 2014 | 44 | 0.500 |
Why?
|
| HIV Seroprevalence | 1 | 2014 | 11 | 0.500 |
Why?
|
| Prediabetic State | 1 | 2015 | 51 | 0.500 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2021 | 375 | 0.500 |
Why?
|
| Gynecology | 1 | 2014 | 31 | 0.490 |
Why?
|
| Mouth Diseases | 1 | 2014 | 6 | 0.490 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 2333 | 0.490 |
Why?
|
| Gastroenterology | 1 | 2013 | 8 | 0.490 |
Why?
|
| Obstetrics | 1 | 2014 | 38 | 0.480 |
Why?
|
| Medical Oncology | 1 | 2013 | 26 | 0.480 |
Why?
|
| Insurance Coverage | 1 | 2014 | 99 | 0.470 |
Why?
|
| Sex Factors | 6 | 2018 | 859 | 0.460 |
Why?
|
| Self Administration | 1 | 2013 | 41 | 0.460 |
Why?
|
| Receptor, erbB-2 | 2 | 2013 | 122 | 0.460 |
Why?
|
| Education, Medical | 1 | 2013 | 97 | 0.440 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 465 | 0.440 |
Why?
|
| Retrospective Studies | 8 | 2021 | 1961 | 0.440 |
Why?
|
| Ambulatory Care | 1 | 2013 | 76 | 0.430 |
Why?
|
| Endometrial Neoplasms | 2 | 2010 | 64 | 0.430 |
Why?
|
| Capacity Building | 1 | 2012 | 78 | 0.420 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 26 | 0.410 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 195 | 0.410 |
Why?
|
| Liver Diseases | 1 | 2011 | 31 | 0.410 |
Why?
|
| Self Care | 1 | 2012 | 150 | 0.400 |
Why?
|
| Patient Selection | 1 | 2012 | 154 | 0.400 |
Why?
|
| Survival Analysis | 4 | 2018 | 322 | 0.400 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 36 | 0.400 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 195 | 0.400 |
Why?
|
| Genetic Testing | 1 | 2011 | 71 | 0.400 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2014 | 165 | 0.390 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1426 | 0.390 |
Why?
|
| Diabetes Complications | 1 | 2011 | 91 | 0.390 |
Why?
|
| Menopause | 3 | 2010 | 54 | 0.390 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 303 | 0.380 |
Why?
|
| Adenoma | 1 | 2011 | 89 | 0.380 |
Why?
|
| Substance-Related Disorders | 2 | 2014 | 685 | 0.370 |
Why?
|
| Socioeconomic Factors | 7 | 2015 | 1003 | 0.360 |
Why?
|
| Insulin Resistance | 1 | 2011 | 177 | 0.350 |
Why?
|
| Vehicle Emissions | 1 | 2009 | 21 | 0.350 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 25 | 0.350 |
Why?
|
| Publishing | 1 | 2009 | 25 | 0.340 |
Why?
|
| Particulate Matter | 1 | 2009 | 49 | 0.340 |
Why?
|
| Urban Population | 2 | 2010 | 318 | 0.340 |
Why?
|
| SEER Program | 4 | 2013 | 87 | 0.340 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 570 | 0.340 |
Why?
|
| Sexual Partners | 4 | 2017 | 308 | 0.320 |
Why?
|
| Minority Groups | 1 | 2012 | 537 | 0.310 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 445 | 0.310 |
Why?
|
| Homosexuality, Male | 3 | 2021 | 438 | 0.310 |
Why?
|
| Environmental Exposure | 1 | 2009 | 207 | 0.300 |
Why?
|
| Smoking | 3 | 2014 | 903 | 0.300 |
Why?
|
| Cost of Illness | 3 | 2017 | 79 | 0.290 |
Why?
|
| Prognosis | 4 | 2018 | 707 | 0.280 |
Why?
|
| Human papillomavirus 16 | 2 | 2018 | 34 | 0.280 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 228 | 0.270 |
Why?
|
| Sex Distribution | 3 | 2014 | 212 | 0.260 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 423 | 0.260 |
Why?
|
| Inflammation | 2 | 2022 | 577 | 0.250 |
Why?
|
| Survival Rate | 4 | 2014 | 310 | 0.250 |
Why?
|
| Child | 6 | 2021 | 2875 | 0.250 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 794 | 0.240 |
Why?
|
| Risk Assessment | 3 | 2018 | 727 | 0.240 |
Why?
|
| Blood Glucose | 3 | 2015 | 333 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 85 | 0.220 |
Why?
|
| Sampling Studies | 2 | 2014 | 60 | 0.220 |
Why?
|
| Population Surveillance | 2 | 2015 | 231 | 0.210 |
Why?
|
| Smoking Cessation | 1 | 2008 | 487 | 0.210 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2021 | 1 | 0.210 |
Why?
|
| Meningococcal Vaccines | 1 | 2021 | 7 | 0.210 |
Why?
|
| Program Evaluation | 2 | 2021 | 316 | 0.200 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 446 | 0.200 |
Why?
|
| Age Distribution | 4 | 2014 | 223 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 424 | 0.190 |
Why?
|
| Medicaid | 1 | 2021 | 102 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2021 | 288 | 0.190 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 555 | 0.190 |
Why?
|
| Unsafe Sex | 2 | 2012 | 161 | 0.190 |
Why?
|
| Urban Health | 2 | 2018 | 86 | 0.180 |
Why?
|
| Schools | 4 | 2021 | 229 | 0.180 |
Why?
|
| Women's Health | 2 | 2010 | 135 | 0.170 |
Why?
|
| Histocytochemistry | 1 | 2018 | 45 | 0.170 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 269 | 0.170 |
Why?
|
| Human papillomavirus 6 | 1 | 2018 | 1 | 0.170 |
Why?
|
| Human papillomavirus 11 | 1 | 2018 | 2 | 0.170 |
Why?
|
| Human papillomavirus 18 | 1 | 2018 | 5 | 0.160 |
Why?
|
| Risk | 4 | 2013 | 256 | 0.160 |
Why?
|
| Data Collection | 2 | 2015 | 188 | 0.160 |
Why?
|
| Feeding Behavior | 2 | 2013 | 418 | 0.160 |
Why?
|
| Hepatitis C | 2 | 2010 | 120 | 0.160 |
Why?
|
| Condylomata Acuminata | 1 | 2017 | 6 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2015 | 196 | 0.150 |
Why?
|
| Students | 1 | 2021 | 452 | 0.150 |
Why?
|
| Confidence Intervals | 2 | 2013 | 151 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 8 | 0.140 |
Why?
|
| Pregnancy | 3 | 2018 | 1503 | 0.140 |
Why?
|
| Penile Diseases | 1 | 2015 | 8 | 0.140 |
Why?
|
| Life Style | 4 | 2010 | 288 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 73 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2013 | 82 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 841 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2016 | 356 | 0.130 |
Why?
|
| Waist-Hip Ratio | 2 | 2011 | 32 | 0.130 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.130 |
Why?
|
| Overweight | 2 | 2014 | 233 | 0.130 |
Why?
|
| Health Personnel | 1 | 2016 | 200 | 0.120 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 20 | 0.120 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.120 |
Why?
|
| Health Care Reform | 1 | 2014 | 31 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 10 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 31 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 1681 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2013 | 80 | 0.120 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 211 | 0.120 |
Why?
|
| Prisoners | 1 | 2014 | 83 | 0.120 |
Why?
|
| HIV Seropositivity | 1 | 2014 | 182 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 114 | 0.110 |
Why?
|
| Syphilis | 1 | 2013 | 27 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 78 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 188 | 0.110 |
Why?
|
| Cluster Analysis | 2 | 2012 | 188 | 0.110 |
Why?
|
| Vegetables | 1 | 2013 | 135 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2013 | 121 | 0.110 |
Why?
|
| Fruit | 1 | 2013 | 159 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 145 | 0.110 |
Why?
|
| Students, Medical | 1 | 2013 | 121 | 0.110 |
Why?
|
| Physicians | 1 | 2013 | 148 | 0.100 |
Why?
|
| Libido | 2 | 2009 | 6 | 0.100 |
Why?
|
| Alcoholism | 1 | 2014 | 220 | 0.100 |
Why?
|
| Probability | 1 | 2012 | 75 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 98 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 14 | 0.100 |
Why?
|
| Biotechnology | 1 | 2011 | 15 | 0.100 |
Why?
|
| Coitus | 1 | 2011 | 13 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2011 | 39 | 0.100 |
Why?
|
| Consumer Health Information | 1 | 2011 | 22 | 0.100 |
Why?
|
| Marketing | 1 | 2011 | 38 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 124 | 0.100 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 9 | 0.100 |
Why?
|
| Efficiency | 1 | 2010 | 17 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 781 | 0.090 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2010 | 12 | 0.090 |
Why?
|
| Herpes Simplex | 1 | 2010 | 16 | 0.090 |
Why?
|
| Quality of Life | 1 | 2014 | 459 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1349 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2010 | 83 | 0.090 |
Why?
|
| Adiposity | 1 | 2011 | 145 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2010 | 46 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 151 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 207 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 531 | 0.090 |
Why?
|
| Dyspareunia | 1 | 2009 | 2 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 15 | 0.090 |
Why?
|
| Information Seeking Behavior | 1 | 2010 | 23 | 0.090 |
Why?
|
| Health Behavior | 1 | 2013 | 491 | 0.090 |
Why?
|
| Vomiting | 1 | 2009 | 13 | 0.090 |
Why?
|
| Nausea | 1 | 2009 | 12 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2011 | 159 | 0.090 |
Why?
|
| Employment | 2 | 2009 | 73 | 0.090 |
Why?
|
| Minerals | 1 | 2009 | 45 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2014 | 541 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 196 | 0.090 |
Why?
|
| Dust | 1 | 2009 | 51 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 580 | 0.080 |
Why?
|
| Health Education | 1 | 2011 | 304 | 0.080 |
Why?
|
| Health Surveys | 1 | 2010 | 358 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2011 | 469 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 147 | 0.070 |
Why?
|
| Parity | 1 | 2006 | 46 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2006 | 104 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2011 | 583 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2018 | 61 | 0.070 |
Why?
|
| Internet | 2 | 2021 | 204 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2006 | 99 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2006 | 429 | 0.060 |
Why?
|
| Educational Status | 3 | 2010 | 295 | 0.060 |
Why?
|
| Public Health | 1 | 2007 | 348 | 0.060 |
Why?
|
| Hypertension | 2 | 2008 | 770 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 7 | 0.050 |
Why?
|
| Depression | 1 | 2008 | 664 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2014 | 613 | 0.040 |
Why?
|
| Colposcopy | 1 | 2018 | 13 | 0.040 |
Why?
|
| Parents | 1 | 2021 | 288 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 363 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 26 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 298 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 605 | 0.030 |
Why?
|
| DNA Probes, HPV | 1 | 2013 | 3 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 50 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 94 | 0.030 |
Why?
|
| Health Facilities | 1 | 2013 | 23 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2012 | 7 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 44 | 0.030 |
Why?
|
| Culture | 1 | 2013 | 162 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 600 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 239 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 132 | 0.030 |
Why?
|
| Complement C4 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 964 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 22 | 0.030 |
Why?
|
| Proteinuria | 1 | 2011 | 48 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 63 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 87 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 52 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2011 | 82 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 137 | 0.020 |
Why?
|
| Diet Records | 1 | 2010 | 56 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 121 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 147 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2010 | 98 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 628 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 143 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2012 | 192 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 41 | 0.020 |
Why?
|
| Vaginal Diseases | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2009 | 10 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 44 | 0.020 |
Why?
|
| Spouses | 1 | 2009 | 29 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 106 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 142 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 253 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2011 | 311 | 0.020 |
Why?
|
| Trust | 1 | 2010 | 119 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 1 | 2007 | 9 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2010 | 393 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 35 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 608 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 1422 | 0.020 |
Why?
|
| Health Status | 1 | 2009 | 356 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 490 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 756 | 0.010 |
Why?
|